Who
M. Kathleen Behrens
Director
Company insider
Files Form 4 as: Director, Sarepta Therapeutics; Director, IGM Biosciences; Director, MiMedx Group; Director, Amylin Pharmaceuticals; Director, Abgenix.
In numbers
- Trades disclosed
- 149
- Buys
- 13
- Sells
- 2
- Bought
- $12.7M
- Sold
- $1.7M
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 1 Apr 2006
- Last trade
- 4 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 5 Jun 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code A | —16,875 | filing |
| 4 Jun 2026filed 5 Jun 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code A | —16,875 | filing |
| 27 Jan 2026filed 29 Jan 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code M | $144K10,500 at $13.71 | filing |
| 27 Jan 2026filed 29 Jan 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $144K6,494 at $22.17 | filing |
| 27 Jan 2026filed 29 Jan 2026 | SRPT Sarepta Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,500 at $0.00 | filing |
| 27 Jan 2026filed 29 Jan 2026 | SRPT Sarepta Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,500 at $0.00 | filing |
| 27 Jan 2026filed 29 Jan 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code M | $144K10,500 at $13.71 | filing |
| 27 Jan 2026filed 29 Jan 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code F | $144K6,494 at $22.17 | filing |
| 14 Aug 2025filed 14 Aug 2025 | IGM Biosciences | SEC FORM 4 Code D | —22,222 | filing |
| 14 Aug 2025filed 14 Aug 2025 | IGM Biosciences | SEC FORM 4 Code D | —330,700 | filing |
| 14 Aug 2025filed 14 Aug 2025 | IGM Biosciences | SEC FORM 4 Code D | —29,807 | filing |
| 14 Aug 2025filed 14 Aug 2025 | IGM Biosciences | SEC FORM 4 Code D | —29,806 | filing |
| 30 Jun 2025filed 2 Jul 2025 | IGM Biosciences | SEC FORM 4 Code A | —1,471 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | $185K28,609 at $6.47 | filing |
| 31 Mar 2025filed 2 Apr 2025 | IGM Biosciences | SEC FORM 4 Code A | —1,471 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | SRPT Sarepta Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,792 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,383 | filing |
| 31 Dec 2024filed 3 Jan 2025 | IGM Biosciences | SEC FORM 4 Code A | —3,078 at $0.00 | filing |
| 30 Sep 2024filed 2 Oct 2024 | IGM Biosciences | SEC FORM 4 Code A | —3,078 at $0.00 | filing |
| 4 Sep 2024filed 5 Sep 2024 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code G | —746 at $0.00 | filing |
News
Comparing Sarepta Therapeutics (NASDAQ:SRPT) and Protagonist Therapeutics (NASDAQ:PTGX)SRPT · dailypolitical.com · 22 Oct 2026Contrasting Sarepta Therapeutics (NASDAQ:SRPT) & AbCellera Biologics (NASDAQ:ABCL)SRPT · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name M. Kathleen Behrens; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.